Summary
In a graded model of the calcium paradox phenomenon (minimal and total) the presence of the β-blocker propranolol (5·10−6M) in the perfusion media (10 min prior to, during and 5 min following calcium-free perfusion) has no effect upon tissue injury. Propranolol pretreatment (three days prior to the experiments) significantly reduced the myocardial enzyme release during calcium repletion in the minimal calcium paradox. The presence of the α1 prazosin (1·10−7M) in the perfusion media (10 min prior to, during and 5 min following calcium-free perfusion) afforded no protective effects. It is concluded that the release of endogenous catecholamines may not be an important factor contributing to myocardial injury in the calcium paradox, and that consequently β- or α1-adrenergic blockade has little if any protective properties in this form of myocardial injury.
Similar content being viewed by others
References
Alto LE, Dhalla NS (1979) Myocardial cation contents during induction of calcium paradox. Am J Physiol 237:H713-H719
Ashraf M, Onda M, Benedict J, Hirohata Y (1981) Surface ultrastructural features of isolated perfused rat hearts during calcium paradox. Scan Electron Microse III:109–114
Boink ABTJ, Ruigrok TJC, Maas AHJ, Zimmerman ANE (1976) Changes in high energy phosphate compounds of isolated rat hearts during Ca2+-free perfusion and reperfusion with Ca2+. J Mol cell Cardiol 8:973–979
Daniell HB, Walle T, Gaffney TE, Webb JG (1979) Stimulation-induced release of propranolol and norepinephrine from adrenergic neurons. J Pharmacol Exp Ther 3:354–359
Frank JS, Langer GA, Nudd LM, Seraydarian K (1977) The myocardial cell surface, its histochemistry and the effect of sialic acid and calcium removal in its structure and cellular ionic exchange. Circ Res 41:702–714
Greve G, Rotevatn S, Sætersdal T, Øksendal AN, Jynge P (1985) Ultrastructural studies of intercalated disc separations in the rat heart during the calcium paradox. Res Exp Med 185:195–206
Hearse DJ, Garlick PB, Humphrey SM, Shillingford JP (1978) The effect of drugs on enzyme release from the hypoxic myocardium. Eur J Cardiol 7:421–436
Hearse DJ, Humphrey SM, Boink ABTJ, Ruigrok TJC (1978) The calcium paradox: metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol 7:241–256
Krebs HA, Hensclcit K (1932) Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Scyler's Physiol Chem 210:33–66
Langendorff O (1895) Untersuchungen am überlebenden Säugetierherzen. Pflügers Arch 61:291–332
Meno H, Kanaide H, Nakamura M (1984) Effects of diltiazem on the calcium paradox in isolated rat hearts. J Pharmacol Exp Ther 228:220–228
Momose M, Ohno O, Ogawa K, Ito T, Hashimoto H, Satake T (1986) Myocardial norepinephrine and cyclic AMP content during calcium free perfusion., J Mol Cell Cardiol 18 (suppl 1):186
Nayler WG, Gordon M, Stephens DJ, Sturrock J (1985) The protective effect of prazosin on the ischaemic and reperfused myocardium. J Mol Cell Cardiol 17:685–699
Nayler WG, Perry SE, Daly MJ (1984) Calcium, sodium and the calcium paradox. Circ Res 55:227–237
Ohhara H, Kanaide H, Nakamura M (1982) A protective effect of verapamil on the calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 14:13–20
Opic LH (1982) Role of cyclic nucleotides in heart metabolism. Cardiovasc Res 16:483–507
Osnes J-B, Refsum H, Skomedal T, Øye I (1978) Qualitative differences between β-adrenergic and α-adrenergic inotropic effects in rat muscle. Acta Pharmacol Toxicol 42:235–247
Rona G (1985) Catecholamine cardiotoxicity. J Mol Cell Cardiol 17:291–306
Rotevatn S, Jodalen H, Øgreid D, Øksendal AN, Jynge P (1986) Myocardial cAMP and calcium levels in the calcium paradox. Basic Res Cardiol 81:430–435
Ruigrok TJC, Burgersdijk FJA, Zimmerman ANE (1975) The calcium paradox: a reaffirmation. Eur J Cardiol 3:59–63
Sellevold OFM, Jynge P, Aarstad K (1986) High performance liquid chromatography: A rapid isocratic method for determination of creatine compounds and adenine nucleotides im myocardial tissue. J Mol Cell cardiol 18:517–527
Skomedal T, Osnes J-B, Øye I (1980) Competitive blockade of α-adrenergic receptors in rat heart by prazosin. Acta Pharmacol Toxicol 47:217–222
Sperelakis N (1984) Cyclic AMP and phosphorylation in regulation of Ca++ influx, into myocardial cells and blockade by calcium antagonistic drugs. Am Heart J 107:347–357
Waldenstrøm AP, Hjalmarson ÅC (1977) Factors modifying ischemic injury in the isolated rat heart. Acta Med Scand 201:533–538
Waldenstrøm AP, Hjalmarson ÅC, Thornell L (1978) A possible role of noradrenaline in the development of myocardial infarction. Am Heart J 95:43–51
Yates JC, Dhalla NS (1975) Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol 7:91–103
Zimmerman ANE, Hülsmann WC (1966) Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211:646–647
Zimmerman ANE, Deams W, Hülsmann WC, Snijder J, Wisse E, Durrer D (1967) Morphological changes of heart muscle caused by successive perfusion with calcium-free and calcium-containing solutions (calcium paradox). Cardiovasc Res 1:201–209
Øksendal AN, Jynge P, Sellevold OFM, Rotevatn S Sætersdal T (1985) The calcium paradox phenomenon: a flow rat and volume response study of calcium-free perfusion. J Mol Cell Cardiol 17:959–972
Øksendal AN, Jynge P (1986) Protection by verapamil in the calcium paradox: dependence on micromolar calcium Cardiovasc Res 20:845–852
Øksendal AN, Jynge P (1986) Myocardial protection by micromolar manganese in the calcium paradox and additive effects of verapamil. Basic Res Cardiol 81:581–593
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Øksendal, A.N., Jynge, P. Tissue protection by adrenergic blockade in the calcium paradox?. Basic Res Cardiol 82, 138–145 (1987). https://doi.org/10.1007/BF01907061
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01907061